Heterogeneous cell-cycle behavior in response to UVB irradiation by a population of single cancer cells visualized by time-lapse FUCCI imaging

References

• Heppner GH, Miller BE. Therapeutic implications of tumor heterogeneity. Semin Oncol 1989; 16:91-105.
   PubMed Web of Science ®Google Scholar
• Schöber C, Gibbs JF, Yin MB, Slocum HK, Rustum YM. Cellular heterogeneity in DNA damage and growth inhibition induced by ICI D1694, thymidylate synthase inhibitor, using single cell assays. Biochem Pharmacol 1994; 48:997-1002; PMID:8093112; http://dx.doi.org/10.1016/0006-2952(94)90370-0
   PubMed Web of Science ®Google Scholar
• Slocum HK, Parsons JC, Winslow EO, Broderick L, Minderman H, Tóth K, Greco WR, Rustum YM. Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694). Cytometry 2000; 41:252-60; PMID:11084610; http://dx.doi.org/10.1002/1097-0320(20001201)41:4%3c252::AID-CYTO3%3e3.0.CO;2-X
   PubMedGoogle Scholar
• Yin MB, Voigt W, Panadero A, Vanhoefer U, Frank C, Pajovic S, Azizkhan J, Rustum YM. p53 and WAF1 are induced and Rb protein is hypophosphorylated during cell growth inhibition by the thymidylate synthase inhibitor ZD1694 (Tomudex). Mol Pharmacol 1997; 51:630-6; PMID:9106628
   PubMed Web of Science ®Google Scholar
• Matsui SI, Arredondo MA, Wrzosek C, Rustum YM. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Cancer Res 1996; 56:4715-23; PMID:8840989
   PubMed Web of Science ®Google Scholar
• Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008; 132:487-98; PMID:18267078; http://dx.doi.org/10.1016/j.cell.2007.12.033
   PubMed Web of Science ®Google Scholar
• Miwa S, Yano S, Kimura H, Yamamoto M, Toneri M, Matsumoto Y, Uehara F, Hiroshima Y, Murakami T, Hayashi K, et al. Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging. Cell-Cycle 2015; 14:621-9; PMID:25551170; http://dx.doi.org/10.4161/15384101.2014.991604, Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Uehara F, Miwa S, Tome Y, Hiroshima Y, Yano S, Yamamoto M, Efimova E, Matsumoto Y, Maehara H, Bouvet M, et al. Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. J Cell Biochem 2014; 115: 1724-8; PMID:24819034; http://dx.doi.org/10.1002/jcb.24837
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. How cancer could be cured by 2015. Cell Cycle 2005; 4:269-78; PMID:15655345
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Tissue-selective therapy of cancer. Br J Cancer 2003; 89:1147-51; PMID:14520435; http://dx.doi.org/10.1038/sj.bjc.6601256
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Matching targets for selective cancer therapy. Drug Discov Today 2003; 8:1104-7; PMID:14678733; http://dx.doi.org/10.1016/S1359-6446(03)02806-X
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. “Targeting the absence” and therapeutic engineering for cancer therapy. Cell Cycle 2008; 7:1307-12; PMID:18487952; http://dx.doi.org/10.4161/cc.7.10.6250
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Teratogens as anti-cancer drugs. Cell Cycle 2005; 4:1518-21; PMID:16258270; http://dx.doi.org/10.4161/cc.4.11.2208
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells. Leukemia 2001; 15:936-41; PMID:11417480; http://dx.doi.org/10.1038/sj.leu.2402127
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Target for cancer therapy: proliferating cells or stem cells. Leukemia 2006; 20:385-91; PMID:16357832; http://dx.doi.org/10.1038/sj.leu.2404075
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Cancer stem cell and cancer stemloids: from biology to therapy. Cancer Biol Ther 2007; 6:1684-90; PMID:18344680; http://dx.doi.org/10.4161/cbt.6.11.5167
   PubMed Web of Science ®Google Scholar
• Yano S, Miwa S, Mii S, Hiroshima Y, Uehara F, Yamamoto M, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, et al. Invading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging. Cell Cycle 2014; 13:953-60; PMID:24552821; http://dx.doi.org/10.4161/cc.27818
   PubMed Web of Science ®Google Scholar
• Yano S, Zhang Y, Miwa S, Tome Y, Hiroshima Y, Uehara F, Yamamoto M, Suetsugu A, Kishimoto H, Tazawa H, et al. Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness. Cell Cycle 2014; 13: 2110-19; PMID:24811200; http://dx.doi.org/10.4161/cc.29156
   PubMed Web of Science ®Google Scholar
• Yano S, Miwa S, Mii S, Hiroshima Y, Uehara F, Kishimoto H, Tazawa H, Zhao M, Bouvet M, Fujiwara T, Hoffman RM. Cancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional Gelfoam® histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging. Cell Cycle 2015; 14: 808-19: PMID:25564963; http://dx.doi.org/10.4161/15384101.2014.989946
   PubMed Web of Science ®Google Scholar
• Yano S, Zhang Y, Zhao M, Hiroshima Y, Miwa S, Uehara F, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, et al. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy. Cell Cycle 2014; 13:3958-63; PMID:25483077; http://dx.doi.org/10.4161/15384101.2014.964115, in press
   PubMed Web of Science ®Google Scholar
• Miwa S, Yano S, Tome Y, Sugimoto N, Hiroshima Y, Uehara F, Mii S, Kimura H, Hayashi K, Efimova EV, et al. Dynamic color-coded fluorescence imaging of the cell-cycle phase mitosis, and apoptosis demonstrates how caffeine modulates cisplatinum efficacy. J Cell Biochem 2013; 114:2454-60; PMID:23696238; http://dx.doi.org/10.1002/jcb.24593
   PubMed Web of Science ®Google Scholar
• Uchugonova A, Duong J, Zhang N, König K, Hoffman RM. The bulge area is the origin of nestin-expressing pluripotent stem cells of the hair follicle. J Cell Biochem 2011; 112: 2046-50; PMID:21465525; http://dx.doi.org/10.1002/jcb.23122
   PubMed Web of Science ®Google Scholar